{"retracted":false,"update":{"timestamp":1470441600000,"doi":"10.1007/s10557-016-6684-z","type":"correction"},"doi":"10.1007/s10557-016-6666-1","journal":"Cardiovascular Drugs and Therapy","publisher":"Springer Nature","title":"Erratum to: Efficacy and Safety of the PCSK9 Inhibitor Evolocumab in Patients with Mixed Hyperlipidemia"}
